← All Investors
NEUBASE THERAPEUTICS INC
OHRPEUR
Holders
1
Combined Value
$100.9K
Combined Shares
136,350
Investor Activity Chart
Quarterly buys (▲) and sells (▼) by tracked investors. Click a marker to view that investor's portfolio; hover for details. Price line is implied from 13F filings (value ÷ shares), not market data.
Held By
Tracked investors currently holding this security, based on each investor's most recent 13F filing. Gain compares the current market price to each investor's estimated average buy price.
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| David Einhorn - Greenlight Capital | $100.9K | 0.00% | ~$1.87 | — | BUY Q2 2023 | Q4 2023 |
Recent Activity
Latest position changes by tracked investors. Prices are estimates implied from 13F filings.
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q2 2023 | David Einhorn - Greenlight Capital | NEW BUY | +$255.0K | ~$1.87 |
Ownership History
Aggregate position across all tracked investors per quarter (options excluded). Implied price is the reported value divided by shares held.
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q4 2023 | 1 | 136,350 | UNCH | $100.9K | $0.74 |
| Q3 2023 | 1 | 136,350 | UNCH | $118.6K | $0.87 |
| Q2 2023 | 1 | 136,350 | — | $255.0K | $1.87 |